NEXEN TIRE Secures Double Honors at the 2025 IDEA Design Awards with FutureOriented Concept Tires
“NEXIST” and “CELLEXIS” recognized for pioneering mobility conceptsInnovative designs highlight solutions for…
C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting
September 20, 2025 11:00 ET | Source: C4 Therapeutics, Inc. Cemsidomide in…
Multiple Myeloma Research Foundation (MMRF) Announces New Data from Flagship Research Initiatives at the 22nd International Myeloma Society Annual Meeting
NORWALK, Conn., Sept. 20, 2025 (GLOBE NEWSWIRE) -- Today, the Multiple Myeloma…
Geri Care hosts 3rd Geri Care Geriatric Conclave & 2nd Asian Geriatric Oncology Society (AGOS) Conference in Bengaluru
BENGALURU, India, Sept. 17, 2025 /PRNewswire/ -- Geri Care, India's pioneer in…
CAS introduces CAS IP Finder for improved intellectual property search
The AI-enhanced solution deepens search capabilities and improves user experience COLUMBUS, Ohio,…
The National Geographic Society and PepsiCo Launch New Food for Tomorrow Program Focused on Regenerative Agriculture
WASHINGTON, Sept. 4, 2025 /PRNewswire/ -- Today, the National Geographic Society and…
Cytokinetics Presents New Data Related to Aficamten at the European Society of Cardiology Congress 2025
Additional Data from MAPLE-HCM Shows Aficamten Improves Cardiac Structure and Function Compared to…
Best Ally in the fight against corruption
HONG KONG, Aug. 28, 2025 /PRNewswire/ -- "Hong Kong, our advantage is…
Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial
- Phase 3 Trial Informed by KARDIA-3 Phase 2 Study Results Presented…
Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine
Positive Trial Demonstrates Superiority of Aficamten to Standard-of-Care Beta-Blocker Metoprolol Primary Endpoint…